Perrigo (NYSE:PRGO) Issues FY 2025 Earnings Guidance

Perrigo (NYSE:PRGO) updated its FY 2025 earnings guidance on Friday. The company provided EPS guidance of 2.900-3.100 for the period, compared to the consensus EPS estimate of 3.020. The company issued revenue guidance of $4.4 billion-$4.5 billion, compared to the consensus revenue estimate of $4.6 billion. Perrigo also updated its FY25 guidance to $2.90-3.10 EPS.

Wall Street Analyst Weigh In

A number of research firms have recently weighed in on PRGO. Piper Sandler lowered Perrigo from an “overweight” rating to a “neutral” rating and cut their price objective for the stock from $34.00 to $27.00 in a research report on Monday, January 6th. StockNews.com downgraded Perrigo from a “buy” rating to a “hold” rating in a report on Wednesday, February 19th. Finally, Argus lowered Perrigo from a “buy” rating to a “hold” rating in a research report on Tuesday, January 14th. Four investment analysts have rated the stock with a hold rating and two have given a buy rating to the company’s stock. According to MarketBeat.com, the stock presently has an average rating of “Hold” and an average target price of $35.00.

Perrigo Stock Up 18.8 %

Shares of PRGO stock traded up $4.55 on Friday, reaching $28.68. 5,785,025 shares of the stock were exchanged, compared to its average volume of 1,491,685. The company has a market capitalization of $3.91 billion, a price-to-earnings ratio of -24.56 and a beta of 0.54. The business’s 50 day moving average price is $24.87 and its 200 day moving average price is $26.18. The company has a current ratio of 2.56, a quick ratio of 1.77 and a debt-to-equity ratio of 0.94. Perrigo has a twelve month low of $23.14 and a twelve month high of $33.46.

Perrigo (NYSE:PRGO) last released its quarterly earnings data on Thursday, February 27th. The company reported $0.93 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.92 by $0.01. Perrigo had a positive return on equity of 7.38% and a negative net margin of 3.64%. The business had revenue of $1.14 billion during the quarter, compared to analysts’ expectations of $1.20 billion. As a group, sell-side analysts expect that Perrigo will post 2.56 earnings per share for the current fiscal year.

Perrigo Increases Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, March 25th. Stockholders of record on Friday, March 7th will be given a dividend of $0.29 per share. This represents a $1.16 annualized dividend and a dividend yield of 4.05%. The ex-dividend date is Friday, March 7th. This is an increase from Perrigo’s previous quarterly dividend of $0.28. Perrigo’s payout ratio is currently -99.15%.

Insider Activity

In other Perrigo news, Director Jeffrey B. Kindler sold 17,598 shares of the firm’s stock in a transaction dated Monday, December 9th. The stock was sold at an average price of $28.27, for a total transaction of $497,495.46. Following the transaction, the director now owns 5,409 shares of the company’s stock, valued at approximately $152,912.43. This trade represents a 76.49 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which can be accessed through this hyperlink. Company insiders own 0.40% of the company’s stock.

Perrigo Company Profile

Perrigo Company plc provides over-the-counter health and wellness solutions to enhance individual well-being in the United States, Europe, and internationally. It operates through Consumer Self-Care Americas and Consumer Self-Care International segments. The company develops, manufactures, markets, and distributes self-care consumer products, such as upper respiratory products, including cough suppressants, expectorants, and sinus and allergy relief; nutrition products consisting of infant formulas and nutritional beverages; digestive health products, including antacids, anti-diarrheal, and anti-heartburn; pain and sleep-aids products comprising pain relievers and fever reducers; and oral care products, which include toothbrushes, toothbrush replacement heads, floss, flossers, whitening products, and toothbrush covers.